Insights into Personalised Medicine in Bronchiectasis

Bronchiectasis is a heterogenous disease with multiple aetiologies resulting in inflammation and dilatation of the airways with associated mucus production and chronic respiratory infection. The condition is being recognised ever more frequently as the availability of computed tomography increases. It is associated with significant morbidity and healthcare-related costs. With new understanding of the disease process, varying endotypes, identification of underlying causes and treatable traits, the management of bronchiectasis can be increasingly personalised.

Automated summary

Bronchiectasis is a diverse disease caused by multiple factors, leading to inflammation and dilation of the airways with excessive mucus production and chronic respiratory infection. As the availability of computed tomography increases, more cases are being diagnosed. It has significant impact on health and healthcare-related costs. With advancements in understanding the disease process, identifying different subtypes, underlying causes, and treatable traits, personalized management of bronchiectasis is becoming possible.